GRAZIA EQUITY’s Post

Very impress phase 1 result, "Updated clinical data on ACTengine® IMA203 targeting PRAME in 30 heavily pre-treated metastatic melanoma patients at RP2D: 55% confirmed objective response rate, including tumor shrinkage achieved in 87% of patients; median duration of response of 13.5 months including 11/16 ongoing confirmed responses; IMA203 continues to maintain a favorable safety profile" 🙂👍👍 More information could find from their presentation slides 😉😉😉 https://lnkd.in/gFi83B7Y

Learn how to create a successful CAR-T therapy by optimizing leukopaks and drug product cryopreservation in this on-demand webinar, "Achieving Consistency in Fill Finish for Cell Therapies." Find out how you can achieve consistency and reduce risks to ensure scale-out strategies for multiple bag requirements and post-thaw viability in a closed environment. Watch now: https://okt.to/SQ1j8G

Excited to share our blog post by Diluks De Silva on navigating the future of CAR T cell therapy development. Gain insights from FDA guidance and stay ahead in this rapidly evolving field. Check it out here: https://lnkd.in/eQ-6uJT7

I received a number of enquiries regarding the topics for the webinar. We will touch on a number of topics, one interesting topic would be "What other companies are doing digitally for biomanufacturing?", we will use case-studies to discuss this. (Webinar registration link - https://lnkd.in/dCjTj8bC) Let's say, you are a Therapeutic company in Phase 2 Cell Therapy trial who outsources all your clinical manufacturing. How can you customize the MES for your own needs? What are other Cell Therapy companies doing?

Biotherapies, including cell therapy products, require sterility and mycoplasma testing. Developing an analytical strategy for detecting impurities like mycoplasma can be challenging. Join us to learn about impurity testing in biotherapies and how rapid detection techniques can enhance confidence in the final product by detecting potential contamination earlier in the production process. Register: https://lnkd.in/eyncUk-p #bioprocessing #biopharma #bioprocessing #qctesting #qualitycontrol #regulatorycontrol #mycoplasma #sterilitytesting #celltherapy

Excited to share our blog post by Diluks De Silva on navigating the future of CAR T cell therapy development. Gain insights from FDA guidance and stay ahead in this rapidly evolving field. Check it out here: https://lnkd.in/eQ-6uJT7

ISPE's ATMP Allogeneic Cell Therapy Guide is here, and our team at CRB is proud of Niranjan Kulkarni for co-authoring the Supply Chain chapter! This Guide is a robust resource with input from several industry experts focusing primarily on allogeneic cell therapies, specifically manufacturing facility development and design. It also outlines common challenges with allogeneic cell therapy facilities, design concepts specific to allogeneic cell therapy facilities, and GMP layout and architectural design development. Learn more about the guide at the link below. #LifeSciences #ATMP #SupplyChain #CellTherapy

ISPE's ATMP Allogeneic Cell Therapy Guide is here, and our team at CRB is proud of Niranjan Kulkarni for co-authoring the Supply Chain chapter! This Guide is a robust resource with input from several industry experts focusing primarily on allogeneic cell therapies, specifically manufacturing facility development and design. It also outlines common challenges with allogeneic cell therapy facilities, design concepts specific to allogeneic cell therapy facilities, and GMP layout and architectural design development. Learn more about the guide at the link below. #LifeSciences #ATMP #SupplyChain #CellTherapy

Biotherapies, including cell therapy products, require sterility and mycoplasma testing. Developing an analytical strategy for detecting impurities like mycoplasma can be challenging. Join us to learn about impurity testing in biotherapies and how rapid detection techniques can enhance confidence in the final product by detecting potential contamination earlier in the production process. Register: https://lnkd.in/eyncUk-p #bioprocessing #biopharma #bioprocessing #qctesting #qualitycontrol #regulatorycontrol #mycoplasma #sterilitytesting #celltherapy

Biotherapies, including cell therapy products, require sterility and mycoplasma testing. Developing an analytical strategy for detecting impurities like mycoplasma can be challenging. Join us to learn about impurity testing in biotherapies and how rapid detection techniques can enhance confidence in the final product by detecting potential contamination earlier in the production process. Register: https://lnkd.in/eyncUk-p #bioprocessing #biopharma #bioprocessing #qctesting #qualitycontrol #regulatorycontrol #mycoplasma #sterilitytesting #celltherapy